Salvage Treatment with Ofatumumab and ESHAP (O-ESHAP) for Patients with Relapsed or Refractory Classical Hodgkin's Lymphoma After First-Line Chemotherapy: Interim Analysis of a Phase II Trial of the Spanish Group of Lymphoma and Bone Marrow Transplantation (GELTAMO)

被引：2
|
作者：
Martinez, Carmen [1 ]
Rodriguez-Calvillo, Mercedes [2 ]
Terol, Maria Jose [3 ]
Xicoy, Blanca [4 ]
Garcia-Sanz, Ramon [5 ]
Perez-Ceballos, Elena [6 ]
Cantalapiedra, Alberto [7 ]
Domingo-Domenech, Eva [8 ]
Hernandez, Miguel [9 ]
Sampol, Antonia [10 ]
Espeso, Manuel [11 ]
Briones, Javier [12 ]
Lopez, Javier [13 ]
Sureda, Anna [14 ]
机构：
[1] Hosp Clin Barcelona, Barcelona, Spain
[2] Complejo Hosp Navarra, Navarra, Spain
[3] Hosp Clin Univ Valencia, Valencia, Spain
[4] Univ Autonoma Barcelona, IJC ICO Badalona, Hosp Germans Trias & Pujol, Badalona, Spain
[5] Univ Hosp Salamanca, Dept Haematol, Salamanca, Spain
[6] Hosp Morales Meseguer, Murcia, Spain
[7] Hosp Rio Hortega, Valladolid, Spain
[8] Inst Catala Oncol, Lhospitalet De Llobregat, Spain
[9] Hosp Univ Canarias, Tenerife, Spain
[10] Hosp Univ Son Dureta, Palma De Mallorca, Spain
[11] Hosp Reg Univ Carlos Haya, Malaga, Spain
[12] Autonomous Univ Barcelona, Barcelona, Spain
[13] Hosp Univ Ramon y Cajal, Serv Hematol & Hemoterapia, Madrid, Spain
[14] Addenbrookes Hosp, Dept Haematol, Cambridge CB2 2QQ, England
来源：
BLOOD | 2012年 / 120卷 / 21期
关键词：
D O I：
10.1182/blood.V120.21.1630.1630
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1630
引用
收藏
页数：2
相关论文
共 47 条
  • [21] Fertility and Gonadal Function after First-Line Treatment with Nivolumab-AVD in Hodgkin Lymphoma Patients: An Analysis from the Phase II GHSG Nivahl Trial
    Broeckelmann, Paul J.
    Buehnen, Ina
    Herhaus, Peter
    Meissner, Julia
    Trautmann-Grill, Karolin
    Mueller, Horst
    Fuchs, Michael
    von Tresckow, Bastian
    Borchmann, Peter
    Engert, Andreas
    Behringer, Karolin
    BLOOD, 2023, 142
  • [22] Autologous bone marrow transplantation for patients with relapsed or refractory diffuse aggressive non-Hodgkin's lymphoma: Value of augmented preparative regimens - A Southwest Oncology Group trial
    Stiff, PJ
    Dahlberg, S
    Forman, SJ
    McCall, AR
    Horning, SJ
    Nademanee, AP
    Blume, KG
    Leblanc, M
    Fisher, RI
    JOURNAL OF CLINICAL ONCOLOGY, 1998, 16 (01) : 48 - 55
  • [23] First-line treatment with brief-duration chemotherapy plus rituximab in elderly patients with intermediate-grade non-Hodgkin's lymphoma: Phase II trial
    Hainsworth, JD
    Litchy, S
    Lamb, MR
    Rodriguez, GI
    Scroggin, C
    Greco, FA
    CLINICAL LYMPHOMA, 2003, 4 (01): : 36 - 42
  • [24] A phase II trial of dexamethasone, high-dose cytarabine, and cisplatin (DHAP) in combination with rituximab as salvage treatment for patients with refractory or relapsed aggressive non-Hodgkin's lymphoma.
    Mey, UJM
    Strehl, JW
    Orlopp, KS
    Flieger, D
    Birkmann, J
    Ho, A
    Kaiser, U
    Neubauer, A
    Glasmacher, AG
    Schmidt-Wolf, IGH
    BLOOD, 2004, 104 (11) : 238B - 238B
  • [25] Rituximab plus short-duration chemotherapy as first-line treatment for follicular non-Hodgkin's lymphoma: A phase II trial of the Minnie Pearl Cancer Research Network
    Hainsworth, JD
    Litchy, S
    Morrissey, LH
    Andrews, MB
    Grimaldi, M
    McCarty, M
    Greco, FA
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (07) : 1500 - 1506
  • [26] Long-term results of high-dose chemotherapy (HDCT) supported by hematopoietic circulating (ASCT) or bone marrow (BMT) stem cell autografting as first salvage treatment for refractory or relapsed Hodgkin's lymphoma.
    Viviani, S.
    Bonfante, V.
    Di Nicola, M.
    Cortelazzo, S.
    Carlostella, C.
    Valagussa, P.
    Bonadonna, G.
    Barbui, T.
    Gianni, A. M.
    JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (18) : 438S - 438S
  • [27] Cost analysis and quality of life assessment comparing patients undergoing autologous peripheral blood stem cell transplantation or autologous bone marrow transplantation for refractory or relapsed non-Hodgkin's lymphoma or Hodgkin's disease: a prospective randomised trial
    van Agthoven, M
    Vellenga, E
    Fibbe, WE
    Kingma, T
    Uyl-de Groot, CA
    EUROPEAN JOURNAL OF CANCER, 2001, 37 (14) : 1781 - 1789
  • [28] Autologous stem cell transplantation for patients aged 60 years or older with refractory or relapsed classical Hodgkin's lymphoma: a retrospective analysis from the French Society of Bone Marrow Transplantation and Cell Therapies (SFGM-TC)
    Stamatoullas, A.
    Brice, P.
    Gueye, M. S.
    Mareschal, S.
    Chevallier, P.
    Bouabdallah, R.
    Nguyenquoc, S.
    Francois, S.
    Turlure, P.
    Ceballos, P.
    Monjanel, H.
    Bourhis, J-H
    Guillerm, G.
    Mohty, M.
    Biron, P.
    Cornillon, J.
    Belhadj, K.
    Bonmati, C.
    Dilhuydy, M-S
    Huynh, A.
    Bernard, M.
    Chretien, M-L
    de Latour, R. Peffault
    Tilly, H.
    BONE MARROW TRANSPLANTATION, 2016, 51 (07) : 928 - 932
  • [29] Autologous stem cell transplantation for patients aged 60 years or older with refractory or relapsed classical Hodgkin’s lymphoma: a retrospective analysis from the French Society of Bone Marrow Transplantation and Cell Therapies (SFGM-TC)
    A Stamatoullas
    P Brice
    M S Gueye
    S Mareschal
    P Chevallier
    R Bouabdallah
    S Nguyenquoc
    S Francois
    P Turlure
    P Ceballos
    H Monjanel
    J-H Bourhis
    G Guillerm
    M Mohty
    P Biron
    J Cornillon
    K Belhadj
    C Bonmati
    M-S Dilhuydy
    A Huynh
    M Bernard
    M-L Chrétien
    R Peffault de Latour
    H Tilly
    Bone Marrow Transplantation, 2016, 51 : 928 - 932
  • [30] Response-adapted treatment with rituximab, bendamustine, mitoxantrone, and dexamethasone followed by rituximab maintenance in patients with relapsed or refractory follicular lymphoma after first-line immunochemotherapy: Results of the RBMDGELTAMO08 phase II trial
    Penalver, Francisco-Javier
    Marquez, Jose-Antonio
    Duran, Soledad
    Giraldo, Pilar
    Martin, Alejandro
    Montalban, Carlos
    Sancho, Juan-Manuel
    Ramirez, Maria-Jose
    Terol, Maria-Jose
    Capote, Francisco-Javier
    Gutierrez, Antonio
    Sanchez, Blanca
    Lopez, Andres
    Salar, Antonio
    Rodriguez-Caravaca, Gil
    Canales, Miguel
    Caballero, Maria-Dolores
    Bello Lopez, Jose Luis
    Carbonell, Felix
    Ferrer Bordas, Secundino
    Font Lopez, Patricia
    Perez Persona, Ernesto
    Lopez Guillermo, Armando
    Hernandez Martin, Roberto
    Ramon Mayans, Jose
    Palomera, Luis
    Perez Ceballos, Elena
    Queizan Hernandez, Jose Antonio
    Riaza Grau, Rosalia
    de la Cruz, Fatima
    Sanchez Salinas, Andres
    CANCER MEDICINE, 2019, 8 (16): : 6955 - 6966
12345